| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.18 | 0.5 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |